What does it take to get a life-changing medicine from regulatory approval to the patient who needs it? Isabell Remus, Global Head of Biosimilars at Sandoz, reveals why being approved and affordable isn't enough – and how the biosimilar industry learned that trust and education must come before market access. With $320 billion in biologic medicines losing patent exclusivity over the next decade, she explores the strategic complexities of launching at the exact moment a patent expires, the role of diversified manufacturing in strengthening supply chain resilience, and why expanding access to essential medications requires both purpose and commercial viability. An eye-opening conversation on making affordable healthcare a reality for millions of patients worldwide.

In this episode, Dr. Kahina Lang, Executive Director and Head of Next Gen Drug Delivery at Merck Group, discusses her pioneering work developing targeted mRNA delivery systems using lipid nanoparticle (LNP) technology. She shares insights on building an internal startup within the world’s oldest pharmaceutical corporation, the technical innovations enabling precision medicine, and the future of cell and gene therapies. Tune in for an insightful conversation on how entrepreneurial leadership, digital-first research approaches, and open-innovation models are accelerating breakthrough therapeutics from the lab to the clinic.

Professor Masayuki Hirata, founder of JiMED and neurosurgeon at Osaka University, explores how brain-computer interfaces are revolutionizing healthcare for people with disability. From helping ALS patients communicate to controlling avatars and restoring motor function, discover the technology uncoding brain signals.

Recorded live at the Strategy& Future of Health Forum, this special episode features Lucy Jones, Chief Clinical Officer at Oviva, on AI-powered nutrition support for chronic disease management, and Dr. Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, on breakthrough blood-based biomarkers revolutionizing Alzheimer's diagnosis. Discover how digital health and diagnostic innovations are creating more accessible, people-centered care.

Dr. Corinna Mann – a specialist in gynecology, endocrinology, and reproductive medicine – unpacks the realities of infertility, age-related success rates across intrauterine insemination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI), and the impact of truly personalized, empathetic care. We examine access and costs, employer-sponsored benefits, and why updating key regulations is overdue, plus the proactive role of social egg freezing. Tune in for a concise, insight-rich conversation on how personalization, prevention, and policy shape the future of health.

Join Dr. Carlos Nunez, Chief Medical Officer at Resmed, for an insightful exploration of the vital connection between sleep and overall health. This episode highlights the revolutionary impact of digital health technologies and AI in helping transform the diagnosis and treatment of sleep apnea – a condition affecting nearly a billion people worldwide, many of whom remain undiagnosed. Discover how heightened awareness and technological advancements are redefining sleep and breathing health, and how innovation is enhancing patient care and engagement.

In this episode of the Strategy& Insider podcast, we explore the transformative role of behavioral science in healthcare with two distinguished experts from the University of Zurich and the University Hospital Zurich: Prof. Dr. Urte Scholz, a psychologist renowned for her work on health behavior change and stress management, joined by Prof. Dr. Claudia Witt, a physician and expert in digital health, mind-body medicine, and integrative oncology. They discuss how our daily habits and behaviors impact our long-term health, while exploring how using psychological principles in medical practices can improve patient care and management.

In this episode of the Strategy& Insider podcast, we explore the transformative role of AI in mental healthcare with Loren Larsen, CEO and co-founder of Videra Health. Loren discusses how his innovative platform is revolutionizing mental health assessments by utilizing video, audio, and chat interactions to enhance patient outcomes and support clinicians. Tune in to explore how AI captures behavioral cues and emotional nuances, offering real-time insights that facilitate early detection and intervention. If you are interested in the future of healthcare technology and the potential of AI to expand access to mental health resources while reducing costs, this episode is a must-listen.

Join Nitya Dintakurti, the pioneering Founder and CEO of Unpause, as she transforms menopause support and women's health. In this episode, we explore the diverse challenges women face during this hormonal transition and how Unpause is reshaping the landscape with cutting-edge technology and innovation. Tune in for a captivating conversation on FemTech and the critical role of personalized and digitized approaches in advancing women's health outcomes.

This episode features Prof. Dr. Robert Perneczky who serves as Professor of Translational Dementia Research and Head of Geriatric Psychiatry at Ludwig-Maximilians University in Munich. Dive into the intricate realm of dementia and neurocognitive disorders as he reveals groundbreaking advancements in disease-modifying treatments and emphasizes the crucial role of lifestyle factors in mitigating dementia risk. Explore how cutting-edge innovations in biomarkers and interdisciplinary methodologies are revolutionizing the future of dementia care and gain insightful strategies to enhance resilience against neurodegeneration.